Advertisement

Index by author

January 01, 1995; Volume 47,Issue 1

A

  1. Andrade, R

    1. Cyclic AMP and protein kinase A mediate 5-hydroxytryptamine type 4 receptor regulation of calcium-activated potassium current in adult hippocampal neurons.
      G E Torres, Y Chaput and R Andrade
      Molecular Pharmacology January 1995, 47 (1) 191-197;

  2. Arnold, D J

    1. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity.
      W J Crumb, B Wible, D J Arnold, J P Payne and A M Brown
      Molecular Pharmacology January 1995, 47 (1) 181-190;

B

  1. Bailly, J D

    1. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
      C Muller, F Goubin, E Ferrandis, I Cornil-Scharwtz, J D Bailly, C Bordier, J Bénard, B I Sikic and G Laurent
      Molecular Pharmacology January 1995, 47 (1) 51-56;

  2. Baricordi, O

    1. A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells.
      F Larini, P Menegazzi, O Baricordi, F Zorzato and S Treves
      Molecular Pharmacology January 1995, 47 (1) 21-28;

  3. Battey, J F

    1. Expression and characterization of cloned human bombesin receptors.
      R V Benya, T Kusui, T K Pradhan, J F Battey and R T Jensen
      Molecular Pharmacology January 1995, 47 (1) 10-20;

  4. Bénard, J

    1. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
      C Muller, F Goubin, E Ferrandis, I Cornil-Scharwtz, J D Bailly, C Bordier, J Bénard, B I Sikic and G Laurent
      Molecular Pharmacology January 1995, 47 (1) 51-56;

  5. Benya, R V

    1. Expression and characterization of cloned human bombesin receptors.
      R V Benya, T Kusui, T K Pradhan, J F Battey and R T Jensen
      Molecular Pharmacology January 1995, 47 (1) 10-20;

  6. Bianchi, B R

    1. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
      C W Lin, T R Miller, D G Witte, B R Bianchi, M Stashko, A M Manelli and D E Frail
      Molecular Pharmacology January 1995, 47 (1) 131-139;

  7. Birdsall, N J

    1. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
      H Matsui, S Lazareno and N J Birdsall
      Molecular Pharmacology January 1995, 47 (1) 88-98;

  8. Bordier, C

    1. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
      C Muller, F Goubin, E Ferrandis, I Cornil-Scharwtz, J D Bailly, C Bordier, J Bénard, B I Sikic and G Laurent
      Molecular Pharmacology January 1995, 47 (1) 51-56;

  9. Bourson, A

    1. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.
      A J Sleight, C Carolo, N Petit, C Zwingelstein and A Bourson
      Molecular Pharmacology January 1995, 47 (1) 99-103;

  10. Brown, A M

    1. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity.
      W J Crumb, B Wible, D J Arnold, J P Payne and A M Brown
      Molecular Pharmacology January 1995, 47 (1) 181-190;

  11. Buckpitt, A

    1. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters.
      A Buckpitt, A M Chang, A Weir, L Van Winkle, X Duan, R Philpot and C Plopper
      Molecular Pharmacology January 1995, 47 (1) 74-81;

  12. Bugge, B

    1. Channel inhibition by alkanols occurs at a binding site on the nicotinic acetylcholine receptor.
      S C Wood, P H Tonner, A J de Armendi, B Bugge and K W Miller
      Molecular Pharmacology January 1995, 47 (1) 121-130;

  13. Burnier, J P

    1. Agonist selectivity for three species of natriuretic peptide receptor-A.
      J R Schoenfeld, P Sehl, C Quan, J P Burnier and D G Lowe
      Molecular Pharmacology January 1995, 47 (1) 172-180;

C

  1. Carolo, C

    1. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.
      A J Sleight, C Carolo, N Petit, C Zwingelstein and A Bourson
      Molecular Pharmacology January 1995, 47 (1) 99-103;

  2. Chang, A M

    1. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters.
      A Buckpitt, A M Chang, A Weir, L Van Winkle, X Duan, R Philpot and C Plopper
      Molecular Pharmacology January 1995, 47 (1) 74-81;

  3. Chang, D Z

    1. Structural analogs of interleukin-2: a point mutation that facilitates biological response.
      D Z Chang, M L Tasayco and T L Ciardelli
      Molecular Pharmacology January 1995, 47 (1) 206-211;

  4. Chaput, Y

    1. Cyclic AMP and protein kinase A mediate 5-hydroxytryptamine type 4 receptor regulation of calcium-activated potassium current in adult hippocampal neurons.
      G E Torres, Y Chaput and R Andrade
      Molecular Pharmacology January 1995, 47 (1) 191-197;

  5. Chen, S T

    1. Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629.
      G M Olins, S T Chen, E G McMahon, M A Palomo and D B Reitz
      Molecular Pharmacology January 1995, 47 (1) 115-120;

  6. Ciardelli, T L

    1. Structural analogs of interleukin-2: a point mutation that facilitates biological response.
      D Z Chang, M L Tasayco and T L Ciardelli
      Molecular Pharmacology January 1995, 47 (1) 206-211;

  7. Cornil-Scharwtz, I

    1. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
      C Muller, F Goubin, E Ferrandis, I Cornil-Scharwtz, J D Bailly, C Bordier, J Bénard, B I Sikic and G Laurent
      Molecular Pharmacology January 1995, 47 (1) 51-56;

  8. Costa, E

    1. Glutamate-induced destabilization of intracellular calcium concentration homeostasis in cultured cerebellar granule cells: role of mitochondria in calcium buffering.
      L Kiedrowski and E Costa
      Molecular Pharmacology January 1995, 47 (1) 140-147;

  9. Couceyro, P

    1. Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain.
      P Couceyro and J Douglass
      Molecular Pharmacology January 1995, 47 (1) 29-39;

  10. Crumb, W J

    1. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity.
      W J Crumb, B Wible, D J Arnold, J P Payne and A M Brown
      Molecular Pharmacology January 1995, 47 (1) 181-190;

D

  1. de Armendi, A J

    1. Channel inhibition by alkanols occurs at a binding site on the nicotinic acetylcholine receptor.
      S C Wood, P H Tonner, A J de Armendi, B Bugge and K W Miller
      Molecular Pharmacology January 1995, 47 (1) 121-130;

  2. de Fiebre, C M

    1. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
      C M de Fiebre, E M Meyer, J C Henry, S I Muraskin, W R Kem and R L Papke
      Molecular Pharmacology January 1995, 47 (1) 164-171;

  3. del Valle, M

    1. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
      R Maroto, M G López, M del Valle, J R Naranjo, B Mellström and A G García
      Molecular Pharmacology January 1995, 47 (1) 40-50;

  4. Douglass, J

    1. Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain.
      P Couceyro and J Douglass
      Molecular Pharmacology January 1995, 47 (1) 29-39;

  5. Duan, X

    1. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters.
      A Buckpitt, A M Chang, A Weir, L Van Winkle, X Duan, R Philpot and C Plopper
      Molecular Pharmacology January 1995, 47 (1) 74-81;

F

  1. Ferrandis, E

    1. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
      C Muller, F Goubin, E Ferrandis, I Cornil-Scharwtz, J D Bailly, C Bordier, J Bénard, B I Sikic and G Laurent
      Molecular Pharmacology January 1995, 47 (1) 51-56;

  2. Fosset, M

    1. Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
      K Meisheri, M Fosset, S Humphrey and M Lazdunski
      Molecular Pharmacology January 1995, 47 (1) 155-163;

  3. Frail, D E

    1. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
      C W Lin, T R Miller, D G Witte, B R Bianchi, M Stashko, A M Manelli and D E Frail
      Molecular Pharmacology January 1995, 47 (1) 131-139;

G

  1. García, A G

    1. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
      R Maroto, M G López, M del Valle, J R Naranjo, B Mellström and A G García
      Molecular Pharmacology January 1995, 47 (1) 40-50;

  2. Goubin, F

    1. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
      C Muller, F Goubin, E Ferrandis, I Cornil-Scharwtz, J D Bailly, C Bordier, J Bénard, B I Sikic and G Laurent
      Molecular Pharmacology January 1995, 47 (1) 51-56;

H

  1. Hadcock, J R

    1. A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14.
      B A Ozenberger and J R Hadcock
      Molecular Pharmacology January 1995, 47 (1) 82-87;

  2. Henderson, C J

    1. Divergent regulation of cytochrome P450 enzymes by morphine and pethidine: a neuroendocrine mechanism?
      A Rane, Z Liu, C J Henderson and C R Wolf
      Molecular Pharmacology January 1995, 47 (1) 57-64;

  3. Henry, J C

    1. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
      C M de Fiebre, E M Meyer, J C Henry, S I Muraskin, W R Kem and R L Papke
      Molecular Pharmacology January 1995, 47 (1) 164-171;

  4. Humphrey, S

    1. Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
      K Meisheri, M Fosset, S Humphrey and M Lazdunski
      Molecular Pharmacology January 1995, 47 (1) 155-163;

J

  1. Jensen, R T

    1. Expression and characterization of cloned human bombesin receptors.
      R V Benya, T Kusui, T K Pradhan, J F Battey and R T Jensen
      Molecular Pharmacology January 1995, 47 (1) 10-20;

K

  1. Kem, W R

    1. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
      C M de Fiebre, E M Meyer, J C Henry, S I Muraskin, W R Kem and R L Papke
      Molecular Pharmacology January 1995, 47 (1) 164-171;

  2. Kiedrowski, L

    1. Glutamate-induced destabilization of intracellular calcium concentration homeostasis in cultured cerebellar granule cells: role of mitochondria in calcium buffering.
      L Kiedrowski and E Costa
      Molecular Pharmacology January 1995, 47 (1) 140-147;

  3. Kusui, T

    1. Expression and characterization of cloned human bombesin receptors.
      R V Benya, T Kusui, T K Pradhan, J F Battey and R T Jensen
      Molecular Pharmacology January 1995, 47 (1) 10-20;

L

  1. Larini, F

    1. A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells.
      F Larini, P Menegazzi, O Baricordi, F Zorzato and S Treves
      Molecular Pharmacology January 1995, 47 (1) 21-28;

  2. Laurent, G

    1. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
      C Muller, F Goubin, E Ferrandis, I Cornil-Scharwtz, J D Bailly, C Bordier, J Bénard, B I Sikic and G Laurent
      Molecular Pharmacology January 1995, 47 (1) 51-56;

  3. Lazareno, S

    1. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
      H Matsui, S Lazareno and N J Birdsall
      Molecular Pharmacology January 1995, 47 (1) 88-98;

  4. Lazdunski, M

    1. Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
      K Meisheri, M Fosset, S Humphrey and M Lazdunski
      Molecular Pharmacology January 1995, 47 (1) 155-163;

  5. Li, F

    1. Functional effects of mutations in the putative agonist binding region of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
      F Li, N Owens and T A Verdoorn
      Molecular Pharmacology January 1995, 47 (1) 148-154;

  6. Lin, C W

    1. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
      C W Lin, T R Miller, D G Witte, B R Bianchi, M Stashko, A M Manelli and D E Frail
      Molecular Pharmacology January 1995, 47 (1) 131-139;

  7. Liu, P C

    1. Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the "adipose- type" and "brain-type" glucose transporters in mice.
      P C Liu and F Matsumura
      Molecular Pharmacology January 1995, 47 (1) 65-73;

  8. Liu, Z

    1. Divergent regulation of cytochrome P450 enzymes by morphine and pethidine: a neuroendocrine mechanism?
      A Rane, Z Liu, C J Henderson and C R Wolf
      Molecular Pharmacology January 1995, 47 (1) 57-64;

  9. López, M G

    1. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
      R Maroto, M G López, M del Valle, J R Naranjo, B Mellström and A G García
      Molecular Pharmacology January 1995, 47 (1) 40-50;

  10. Lowe, D G

    1. Agonist selectivity for three species of natriuretic peptide receptor-A.
      J R Schoenfeld, P Sehl, C Quan, J P Burnier and D G Lowe
      Molecular Pharmacology January 1995, 47 (1) 172-180;

M

  1. Malayev, A A

    1. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel.
      A A Malayev, D J Nelson and L H Philipson
      Molecular Pharmacology January 1995, 47 (1) 198-205;

  2. Manelli, A M

    1. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
      C W Lin, T R Miller, D G Witte, B R Bianchi, M Stashko, A M Manelli and D E Frail
      Molecular Pharmacology January 1995, 47 (1) 131-139;

  3. Maroto, R

    1. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
      R Maroto, M G López, M del Valle, J R Naranjo, B Mellström and A G García
      Molecular Pharmacology January 1995, 47 (1) 40-50;

  4. Matsui, H

    1. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
      H Matsui, S Lazareno and N J Birdsall
      Molecular Pharmacology January 1995, 47 (1) 88-98;

  5. Matsumura, F

    1. Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the "adipose- type" and "brain-type" glucose transporters in mice.
      P C Liu and F Matsumura
      Molecular Pharmacology January 1995, 47 (1) 65-73;

  6. McMahon, E G

    1. Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629.
      G M Olins, S T Chen, E G McMahon, M A Palomo and D B Reitz
      Molecular Pharmacology January 1995, 47 (1) 115-120;

  7. Meisheri, K

    1. Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
      K Meisheri, M Fosset, S Humphrey and M Lazdunski
      Molecular Pharmacology January 1995, 47 (1) 155-163;

  8. Mellström, B

    1. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
      R Maroto, M G López, M del Valle, J R Naranjo, B Mellström and A G García
      Molecular Pharmacology January 1995, 47 (1) 40-50;

  9. Menegazzi, P

    1. A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells.
      F Larini, P Menegazzi, O Baricordi, F Zorzato and S Treves
      Molecular Pharmacology January 1995, 47 (1) 21-28;

  10. Meyer, E M

    1. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
      C M de Fiebre, E M Meyer, J C Henry, S I Muraskin, W R Kem and R L Papke
      Molecular Pharmacology January 1995, 47 (1) 164-171;

  11. Miller, K W

    1. Channel inhibition by alkanols occurs at a binding site on the nicotinic acetylcholine receptor.
      S C Wood, P H Tonner, A J de Armendi, B Bugge and K W Miller
      Molecular Pharmacology January 1995, 47 (1) 121-130;

  12. Miller, T R

    1. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
      C W Lin, T R Miller, D G Witte, B R Bianchi, M Stashko, A M Manelli and D E Frail
      Molecular Pharmacology January 1995, 47 (1) 131-139;

  13. Muller, C

    1. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
      C Muller, F Goubin, E Ferrandis, I Cornil-Scharwtz, J D Bailly, C Bordier, J Bénard, B I Sikic and G Laurent
      Molecular Pharmacology January 1995, 47 (1) 51-56;

  14. Muraskin, S I

    1. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
      C M de Fiebre, E M Meyer, J C Henry, S I Muraskin, W R Kem and R L Papke
      Molecular Pharmacology January 1995, 47 (1) 164-171;

N

  1. Naranjo, J R

    1. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
      R Maroto, M G López, M del Valle, J R Naranjo, B Mellström and A G García
      Molecular Pharmacology January 1995, 47 (1) 40-50;

  2. Nelson, D J

    1. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel.
      A A Malayev, D J Nelson and L H Philipson
      Molecular Pharmacology January 1995, 47 (1) 198-205;

O

  1. Olins, G M

    1. Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629.
      G M Olins, S T Chen, E G McMahon, M A Palomo and D B Reitz
      Molecular Pharmacology January 1995, 47 (1) 115-120;

  2. Owens, N

    1. Functional effects of mutations in the putative agonist binding region of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
      F Li, N Owens and T A Verdoorn
      Molecular Pharmacology January 1995, 47 (1) 148-154;

  3. Ozenberger, B A

    1. A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14.
      B A Ozenberger and J R Hadcock
      Molecular Pharmacology January 1995, 47 (1) 82-87;

P

  1. Palomo, M A

    1. Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629.
      G M Olins, S T Chen, E G McMahon, M A Palomo and D B Reitz
      Molecular Pharmacology January 1995, 47 (1) 115-120;

  2. Papke, R L

    1. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
      C M de Fiebre, E M Meyer, J C Henry, S I Muraskin, W R Kem and R L Papke
      Molecular Pharmacology January 1995, 47 (1) 164-171;

  3. Payne, J P

    1. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity.
      W J Crumb, B Wible, D J Arnold, J P Payne and A M Brown
      Molecular Pharmacology January 1995, 47 (1) 181-190;

  4. Pedersen, S E

    1. Site-selective photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor by azide derivatives of ethidium bromide.
      S E Pedersen
      Molecular Pharmacology January 1995, 47 (1) 1-9;

  5. Petit, N

    1. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.
      A J Sleight, C Carolo, N Petit, C Zwingelstein and A Bourson
      Molecular Pharmacology January 1995, 47 (1) 99-103;

  6. Philipson, L H

    1. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel.
      A A Malayev, D J Nelson and L H Philipson
      Molecular Pharmacology January 1995, 47 (1) 198-205;

  7. Philpot, R

    1. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters.
      A Buckpitt, A M Chang, A Weir, L Van Winkle, X Duan, R Philpot and C Plopper
      Molecular Pharmacology January 1995, 47 (1) 74-81;

  8. Plopper, C

    1. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters.
      A Buckpitt, A M Chang, A Weir, L Van Winkle, X Duan, R Philpot and C Plopper
      Molecular Pharmacology January 1995, 47 (1) 74-81;

  9. Pradhan, T K

    1. Expression and characterization of cloned human bombesin receptors.
      R V Benya, T Kusui, T K Pradhan, J F Battey and R T Jensen
      Molecular Pharmacology January 1995, 47 (1) 10-20;

Q

  1. Quan, C

    1. Agonist selectivity for three species of natriuretic peptide receptor-A.
      J R Schoenfeld, P Sehl, C Quan, J P Burnier and D G Lowe
      Molecular Pharmacology January 1995, 47 (1) 172-180;

R

  1. Rane, A

    1. Divergent regulation of cytochrome P450 enzymes by morphine and pethidine: a neuroendocrine mechanism?
      A Rane, Z Liu, C J Henderson and C R Wolf
      Molecular Pharmacology January 1995, 47 (1) 57-64;

  2. Reitz, D B

    1. Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629.
      G M Olins, S T Chen, E G McMahon, M A Palomo and D B Reitz
      Molecular Pharmacology January 1995, 47 (1) 115-120;

S

  1. Schoenfeld, J R

    1. Agonist selectivity for three species of natriuretic peptide receptor-A.
      J R Schoenfeld, P Sehl, C Quan, J P Burnier and D G Lowe
      Molecular Pharmacology January 1995, 47 (1) 172-180;

  2. Sehl, P

    1. Agonist selectivity for three species of natriuretic peptide receptor-A.
      J R Schoenfeld, P Sehl, C Quan, J P Burnier and D G Lowe
      Molecular Pharmacology January 1995, 47 (1) 172-180;

  3. Sikic, B I

    1. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
      C Muller, F Goubin, E Ferrandis, I Cornil-Scharwtz, J D Bailly, C Bordier, J Bénard, B I Sikic and G Laurent
      Molecular Pharmacology January 1995, 47 (1) 51-56;

  4. Sleight, A J

    1. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.
      A J Sleight, C Carolo, N Petit, C Zwingelstein and A Bourson
      Molecular Pharmacology January 1995, 47 (1) 99-103;

  5. Stashko, M

    1. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
      C W Lin, T R Miller, D G Witte, B R Bianchi, M Stashko, A M Manelli and D E Frail
      Molecular Pharmacology January 1995, 47 (1) 131-139;

T

  1. Tasayco, M L

    1. Structural analogs of interleukin-2: a point mutation that facilitates biological response.
      D Z Chang, M L Tasayco and T L Ciardelli
      Molecular Pharmacology January 1995, 47 (1) 206-211;

  2. Thomopoulos, P

    1. ADP and ATP activate distinct signaling pathways in human promonocytic U-937 cells differentiated with 1,25-dihydroxy-vitamin D3.
      M A Ventura and P Thomopoulos
      Molecular Pharmacology January 1995, 47 (1) 104-114;

  3. Tonner, P H

    1. Channel inhibition by alkanols occurs at a binding site on the nicotinic acetylcholine receptor.
      S C Wood, P H Tonner, A J de Armendi, B Bugge and K W Miller
      Molecular Pharmacology January 1995, 47 (1) 121-130;

  4. Torres, G E

    1. Cyclic AMP and protein kinase A mediate 5-hydroxytryptamine type 4 receptor regulation of calcium-activated potassium current in adult hippocampal neurons.
      G E Torres, Y Chaput and R Andrade
      Molecular Pharmacology January 1995, 47 (1) 191-197;

  5. Treves, S

    1. A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells.
      F Larini, P Menegazzi, O Baricordi, F Zorzato and S Treves
      Molecular Pharmacology January 1995, 47 (1) 21-28;

V

  1. Van Winkle, L

    1. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters.
      A Buckpitt, A M Chang, A Weir, L Van Winkle, X Duan, R Philpot and C Plopper
      Molecular Pharmacology January 1995, 47 (1) 74-81;

  2. Ventura, M A

    1. ADP and ATP activate distinct signaling pathways in human promonocytic U-937 cells differentiated with 1,25-dihydroxy-vitamin D3.
      M A Ventura and P Thomopoulos
      Molecular Pharmacology January 1995, 47 (1) 104-114;

  3. Verdoorn, T A

    1. Functional effects of mutations in the putative agonist binding region of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
      F Li, N Owens and T A Verdoorn
      Molecular Pharmacology January 1995, 47 (1) 148-154;

W

  1. Weir, A

    1. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters.
      A Buckpitt, A M Chang, A Weir, L Van Winkle, X Duan, R Philpot and C Plopper
      Molecular Pharmacology January 1995, 47 (1) 74-81;

  2. Wible, B

    1. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity.
      W J Crumb, B Wible, D J Arnold, J P Payne and A M Brown
      Molecular Pharmacology January 1995, 47 (1) 181-190;

  3. Witte, D G

    1. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
      C W Lin, T R Miller, D G Witte, B R Bianchi, M Stashko, A M Manelli and D E Frail
      Molecular Pharmacology January 1995, 47 (1) 131-139;

  4. Wolf, C R

    1. Divergent regulation of cytochrome P450 enzymes by morphine and pethidine: a neuroendocrine mechanism?
      A Rane, Z Liu, C J Henderson and C R Wolf
      Molecular Pharmacology January 1995, 47 (1) 57-64;

  5. Wood, S C

    1. Channel inhibition by alkanols occurs at a binding site on the nicotinic acetylcholine receptor.
      S C Wood, P H Tonner, A J de Armendi, B Bugge and K W Miller
      Molecular Pharmacology January 1995, 47 (1) 121-130;

Z

  1. Zorzato, F

    1. A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells.
      F Larini, P Menegazzi, O Baricordi, F Zorzato and S Treves
      Molecular Pharmacology January 1995, 47 (1) 21-28;

  2. Zwingelstein, C

    1. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.
      A J Sleight, C Carolo, N Petit, C Zwingelstein and A Bourson
      Molecular Pharmacology January 1995, 47 (1) 99-103;
Back to top

In this issue